The study particularly highlighted the inhibition of SRC, STAT3, PIK3CA, MAPK1, EGFR, and JAK1 through molecular docking, which are key proteins involved in the EGFR Tyrosine Kinase Inhibitor Resistance pathway in NSCLC. Here, STAT3 is linked to non-small cell lung carcinoma.